Related Experiment Video

Updated: Jun 4, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Adjunctive pharmacologic therapy in percutaneous coronary intervention: part II anticoagulant therapy

Soo-Joong Kim1, Robert P Giugliano, Ik-Kyung Jang

  • 1Department of Cardiology, College of Medicine, Kyung Hee University Medical Center, Seoul, Korea.

Coronary Artery Disease
|February 10, 2011
PubMed

Insights

New anticoagulants offer alternatives to unfractionated heparin (UFH) for preventing blood clots during percutaneous coronary intervention. These agents, including low-molecular weight heparins and factor Xa inhibitors, are crucial for patient safety.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Interventional Cardiology

Background:

  • Percutaneous coronary intervention (PCI) requires pharmacological therapies to prevent thrombotic complications.
  • Anticoagulant therapy is essential during PCI, alongside antiplatelet agents.
  • Unfractionated heparin (UFH) is a conventional anticoagulant used in PCI.

Purpose of the Study:

  • To review and compare newer anticoagulant agents with UFH for PCI.
  • To highlight alternatives for managing procedure-related thrombosis.

Main Methods:

  • Literature review of pharmacological adjuvant therapies for PCI.
  • Comparison of different classes of anticoagulants against UFH.

Main Results:

  • Newer anticoagulants provide alternatives to UFH.
  • Low-molecular weight heparins, direct thrombin inhibitors (e.g., bivalirudin), and factor Xa inhibitors (e.g., fondaparinux) are discussed.
  • These agents offer options for preventing thrombotic complications.

Conclusions:

  • Novel anticoagulant agents represent advancements in managing PCI-related thrombotic risks.
  • The availability of diverse anticoagulants improves therapeutic options beyond UFH.

More Related Videos

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...